Subscribe To
Rosen, a globally respected law firm, encourages uipath, inc. investors with losses to secure counsel before important deadline in securities class action – path
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ui...
October 10, 2023, 4:45 pm
Onto innovation to report third quarter 2023 financial results on november 9, 2023
WILMINGTON, Mass.--(BUSINESS WIRE)---- $ONTO--Onto Innovation Inc. (NYSE: ONTO) will release its 2023 third quarter results shortly after the market c...
October 10, 2023, 4:41 pm
Federal judge throws out $32.5 million win for sonos against google
A California judge has thrown out a $32.5 million verdict win for Sonos against Google after two of Sonos' pat...
October 10, 2023, 4:37 pm
Trustco to release third quarter 2023 results on october 23, 2023; conference call on october 24, 2023
GLENVILLE, N.Y., Oct. 10, 2023 (GLOBE NEWSWIRE) -- TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced that it will release third quarter 202...
October 10, 2023, 4:00 pm
Rayzebio: initiating coverage with buy rating and a price target of $43
Initiating RayzeBio, Inc. coverage with a Buy rating and common stock price target of $43 based on my risk-adjusted NPV discounted cash flow model, re...
October 10, 2023, 2:10 pm
Heritage global to present at the virtual tech conference series: exploring all corners of the tech sector, presented by maxim group on wednesday, october 11, 2023
SAN DIEGO--(BUSINESS WIRE)--Heritage Global, Inc. (NASDAQ: HGBL) (“Heritage Global,” “HG” or “the Company”), an asset services company spe...
October 10, 2023, 12:30 pm
Tesla charges north, pulls cathie wood-led arkk and 2x leveraged tark etfs higher: a technical analysis
Tesla, Inc TSLA was rising over 3% on Tuesday, breaking up from a bull flag pattern on the daily chart....
October 10, 2023, 12:16 pm
Alnylam (alny) receives crl for the label expansion of onpattro
Alnylam's (ALNY) label expansion-seeking application for Onpattro, to treat transthyretin-mediated amyl...
October 10, 2023, 12:01 pm
Akero therapeutics inc stock tanks after nash liver treatment study disappoints
Akero Therapeutics Inc shares lost roughly two-thirds of their value Tuesday morning after the company released a disappointing update on its fatty li...
October 10, 2023, 11:51 am
Why akero therapeutics stock is crashing today
Akero's experimental NASH drug efruxifermin (EFX) missed its primary endpoint in a phase 2b study. However, statistically significant improvement was ...
October 10, 2023, 11:44 am
Kforce inc. announces its participation at j.p. morgan ultimate services investor conference and northcoast research fall forum
TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC), a provider of professional staffing services and solutions, today announce...
October 10, 2023, 11:30 am
Bridgebio pharma announces new england journal of medicine publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (adh1)
– In our study, encaleret restored physiologic mineral homeostasis in 13 participants with ADH1, specifically correcting hypocalcemia and reducing h...
October 10, 2023, 11:30 am
Windtree to participate in the lytham partners fall 2023 investor conference on october 17th
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...
October 10, 2023, 11:30 am
Lyra therapeutics: hold for phase 3 topline
Lyra Therapeutics has two product candidates in clinical trials for Chronic rhinosinusitis (CRS) patien...
October 10, 2023, 10:56 am
Unattended ground sensors (ugs) market to register us$ 731.4 million by 2033 amid growing geopolitical tensions worldwide | future market insights
Unattended Ground Sensors (UGS) Market set for robust growth, driven by security concerns, technology integration, and regional dynamics. NEWARK, Del,...
October 10, 2023, 10:30 am
Merck immunotherapy shows further promise in lung cancer
Merck & Co confirmed that its cancer drug Keytruda has successfully met the second of its two primary targets in a phase III clinical trial, showi...
October 10, 2023, 9:11 am
Audchf short term forecast and technical analysis
Hi Traders! AUDCHF short term forecast and technical analysis is here. We do our analysis on the MetaTrader4 platform (MT4), some very interesting, us...
October 10, 2023, 8:39 am
Europe viscosupplementation market to exceed us$ 12.03 billion by 2033, expanding at a 9.37% cagr | future market insights, inc.
In the United Kingdom, several viscosupplementation products have gained regulatory approval, providing a range of therapeutic options for both ...
October 10, 2023, 8:30 am
Akero therapeutics shares plunge on liver disease treatment's mixed results
Akero Therapeutics Inc. shares AKRO, -3.56% fell more than 60% premarket on Tuesday after the company released an update on its lead product candidate...
October 10, 2023, 8:10 am
Lexicon pharmaceuticals shares rise on express scripts support for inpefa heart drug
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares jumped 9% in Tuesday pre-market trading after it announced that its Inpefa heart failure drug has ...
October 10, 2023, 7:47 am